The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2567
Publisher
MDPI AG
Online
2020-09-11
DOI
10.3390/cancers12092567
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing Chimeric Antigen Receptor T cell Efficacy in Solid Tumors
- (2020) Giovanni Fucá et al. CLINICAL CANCER RESEARCH
- Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
- (2020) Dongrui Wang et al. Science Translational Medicine
- Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
- (2020) Aleksei Titov et al. Cancers
- Revving the CAR – Combination strategies to enhance CAR T cell effectiveness
- (2020) Rajat Bansal et al. BLOOD REVIEWS
- Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase 1 Trials
- (2020) Donghua Shi et al. CLINICAL CANCER RESEARCH
- CARs: Beyond T Cells and T Cell-Derived Signaling Domains
- (2020) Nico M. Sievers et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
- (2020) Mary S. Pampusch et al. Jove-Journal of Visualized Experiments
- Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?
- (2020) Chiara F Magnani et al. Cells
- Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
- (2020) Uri Greenbaum et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The old CEACAMs find their new role in tumor immunotherapy
- (2020) Zi-Wen Han et al. INVESTIGATIONAL NEW DRUGS
- Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
- (2020) Emmanuel Donnadieu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
- (2020) Isabella Monia Montagner et al. Cells
- Cancer-associated mucins: role in immune modulation and metastasis
- (2019) Rakesh Bhatia et al. CANCER AND METASTASIS REVIEWS
- Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety—A Systematic Review with Meta-Analysis
- (2019) Wen-Liang Yu et al. Cancers
- Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
- (2019) Benjamin Heyman et al. Cancers
- Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
- (2019) Stephanie L. Goff et al. JOURNAL OF IMMUNOTHERAPY
- Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors
- (2019) Anna Schurich et al. Immunotherapy
- Ligand-inducible, prostate stem cell antigen (PSCA)-directed GoCAR-T cells in advanced solid tumors: Preliminary results with cyclophosphamide (Cy) ± fludarabine (Flu) lymphodepletion (LD).
- (2019) Carlos Roberto Becerra et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I trial of Claudin 18.2-specific chimeric antigen receptor T cells for advanced gastric and pancreatic adenocarcinoma.
- (2019) Xianbao Zhan et al. JOURNAL OF CLINICAL ONCOLOGY
- Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent.
- (2019) Prasad S. Adusumilli et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation
- (2019) Poshmaal Dhar et al. Frontiers in Cellular and Infection Microbiology
- Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
- (2019) Stefan Stoiber et al. Cells
- SO-009Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer
- (2019) E Van Cutsem et al. ANNALS OF ONCOLOGY
- Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
- (2019) Lorraine Springuel et al. BIODRUGS
- HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
- (2019) Steven C. Katz et al. CANCER GENE THERAPY
- CAR T cells for brain tumors: Lessons learned and road ahead
- (2019) David Akhavan et al. IMMUNOLOGICAL REVIEWS
- CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia
- (2019) Dennis C. Harrer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I study of lentiviral-transduced chimeric antigen receptor modified T cells recognizing mesothelin in advanced solid cancers
- (2019) Andrew R. Haas et al. MOLECULAR THERAPY
- Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
- (2019) Rui-Mei Feng et al. Cancer Communications
- CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms
- (2019) Emiliano Roselli et al. BIODRUGS
- An update on emerging drugs in osteosarcoma: towards tailored therapies?
- (2019) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance
- (2019) Manuel Wiesinger et al. Cancers
- Determinants of response and resistance to CAR T cell therapy
- (2019) Stefanie Lesch et al. SEMINARS IN CANCER BIOLOGY
- Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment
- (2019) Zijun Zhao et al. Science China-Life Sciences
- Latest developments in MUC1 immunotherapy
- (2018) Joyce Taylor-Papadimitriou et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR
- (2018) Miguel-Angel Perales et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Non-viral RNA chimeric antigen receptor modified T cells in patients with Hodgkin lymphoma
- (2018) Jakub Svoboda et al. BLOOD
- Antigenic targets of CAR T Cell Therapy. A retrospective view on clinical trials
- (2018) Fatemeh Arabi et al. EXPERIMENTAL CELL RESEARCH
- Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
- (2018) Gregory L. Beatty et al. GASTROENTEROLOGY
- Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race
- (2018) Dennis C. Harrer et al. HUMAN GENE THERAPY
- BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
- (2018) Jan Dörrie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
- (2018) Jian Li et al. Journal of Hematology & Oncology
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia
- (2018) Zhi Cheng et al. MOLECULAR THERAPY
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- A Rapamycin-Activated Caspase 9-Based Suicide Gene
- (2018) Maria Stavrou et al. MOLECULAR THERAPY
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- CAR T-Cell Therapy in Large B-Cell Lymphoma
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma
- (2018) Francesco Ceppi et al. TRANSFUSION
- Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
- (2018) Xing-Chun Peng et al. Cancer Medicine
- Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
- (2018) Carter M. Suryadevara et al. OncoImmunology
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates
- (2018) Mei Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Abstract CT131: A phase I study of adoptive immunotherapy for advanced ROR1+ malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)
- (2018) Jennifer M. Specht et al. CANCER RESEARCH
- Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma
- (2018) Karin Straathof et al. CANCER RESEARCH
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- Mucins and Their Role in Shaping the Functions of Mucus Barriers
- (2018) C.E. Wagner et al. Annual Review of Cell and Developmental Biology
- Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system
- (2018) Michael Hudecek et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A Review on Electroporation-Based Intracellular Delivery
- (2018) Junfeng Shi et al. MOLECULES
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
- (2018) Journal for ImmunoTherapy of Cancer
- Transposons: Moving Forward from Preclinical Studies to Clinical Trials
- (2017) Jaitip Tipanee et al. HUMAN GENE THERAPY
- Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
- (2017) Wenpeng Li et al. HUMAN GENE THERAPY
- Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
- (2017) Kai-chao Feng et al. Journal of Hematology & Oncology
- Chimeric antigen receptor T cells: a novel therapy for solid tumors
- (2017) Shengnan Yu et al. Journal of Hematology & Oncology
- Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells
- (2017) Janos L. Tanyi et al. JOURNAL OF IMMUNOTHERAPY
- Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
- (2017) David F. Stroncek et al. Journal of Translational Medicine
- Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
- (2017) Kentaro Inamura et al. LUNG CANCER
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
- (2017) Andras Heczey et al. MOLECULAR THERAPY
- Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40
- (2017) Aaron E. Foster et al. MOLECULAR THERAPY
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
- (2017) Khun Visith Keu et al. Science Translational Medicine
- Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
- (2017) Thomas Shum et al. Cancer Discovery
- Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
- (2017) Caroline Lonez et al. BMJ Open
- Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
- (2017) Kaichao Feng et al. Protein & Cell
- Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
- (2017) Zhenguang Wang et al. Protein & Cell
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- New Chimeric Antigen Receptor Design for Solid Tumors
- (2017) Yuedi Wang et al. Frontiers in Immunology
- Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
- (2017) Zhiwu Jiang et al. Frontiers in Immunology
- Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
- (2017) Hamid R. Mirzaei et al. Frontiers in Immunology
- PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
- (2017) Xinru Wei et al. OncoImmunology
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy
- (2017) et al. Cancers
- Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model”
- (2017) Endang Purba et al. Cells
- The growing world of CAR T cell trials: a systematic review
- (2016) Astrid Holzinger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
- (2016) Xiaojun Liu et al. CANCER RESEARCH
- Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
- (2016) E. Picarda et al. CLINICAL CANCER RESEARCH
- Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma
- (2016) Ugur Uslu et al. EXPERIMENTAL DERMATOLOGY
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
- (2016) Andrea Schietinger et al. IMMUNITY
- Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives
- (2016) José Eduardo Vargas et al. Journal of Translational Medicine
- GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade
- (2016) Tessa Gargett et al. MOLECULAR THERAPY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response
- (2016) Richard P. Junghans et al. PROSTATE
- Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
- (2016) B Benzon et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
- (2016) Fengtao You et al. Science China-Life Sciences
- Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
- (2016) Kaichao Feng et al. Science China-Life Sciences
- IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia
- (2016) Aizhang Xu et al. Cell and Bioscience
- Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
- (2016) Anke Redeker et al. Frontiers in Immunology
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone
- (2015) Christian Krug et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
- (2015) A. Lo et al. CANCER RESEARCH
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
- (2015) S. C. Katz et al. CLINICAL CANCER RESEARCH
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
- (2015) Mythili Koneru et al. Journal of Translational Medicine
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
- (2015) Laura A. Johnson et al. Science Translational Medicine
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- Designing CAR T cells for glioblastoma
- (2015) Marcela V Maus OncoImmunology
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
- (2015) Nabil Ahmed et al. Journal for ImmunoTherapy of Cancer
- Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases
- (2014) A Saied et al. CANCER GENE THERAPY
- Overcoming the toxicity hurdles of genetically targeted T cells
- (2014) Monica Casucci et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NKG2D signaling in cancer immunosurveillance
- (2014) Alejandro López-Soto et al. INTERNATIONAL JOURNAL OF CANCER
- Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
- (2014) Ge Zhang et al. Scientific Reports
- T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression
- (2014) S. P. Santoro et al. Cancer Immunology Research
- Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor microenvironment
- (2014) Gregory L Beatty et al. OncoImmunology
- TGF-β Activation and Function in Immunity
- (2013) Mark A. Travis et al. Annual Review of Immunology
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis
- (2013) Nicole Beauchemin et al. CANCER AND METASTASIS REVIEWS
- The Weal and Woe of Costimulation in the Adoptive Therapy of Cancer with Chimeric Antigen Receptor (CAR)-Redirected T Cells
- (2013) A. Hombach et al. CURRENT MOLECULAR MEDICINE
- Clinical trials in cellular immunotherapy for brain/CNS tumors
- (2013) Jetan Badhiwala et al. Expert Review of Neurotherapeutics
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody
- (2013) Ge Zhang et al. IMMUNOLOGY AND CELL BIOLOGY
- Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
- (2013) Marco L. Davila et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Genetically engineered T cells for the treatment of cancer
- (2013) M. Essand et al. JOURNAL OF INTERNAL MEDICINE
- Decreased functional T lymphocyte-mediated cytokine responses in patients with chemotherapy-induced neutropenia
- (2013) L. Öhrmalm et al. JOURNAL OF INTERNAL MEDICINE
- Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
- (2013) Petra C Schuberth et al. Journal of Translational Medicine
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma
- (2013) Lihua E. Budde et al. PLoS One
- B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
- (2013) Xiao Qin et al. OncoTargets and Therapy
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans
- (2013) M. V. Maus et al. Cancer Immunology Research
- Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer
- (2013) May C.I. van Schalkwyk et al. Human Gene Therapy Clinical Development
- Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation
- (2012) Lena Oevermann et al. Annals of the New York Academy of Sciences
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
- (2012) Ulf Petrausch et al. BMC CANCER
- CD27 Signaling Increases the Frequency of Regulatory T Cells and Promotes Tumor Growth
- (2012) C. Claus et al. CANCER RESEARCH
- The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
- (2012) D. W. Lee et al. CLINICAL CANCER RESEARCH
- Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
- (2012) Richard A. Morgan et al. HUMAN GENE THERAPY
- CD70 expression patterns in renal cell carcinoma
- (2012) Lucia B. Jilaveanu et al. HUMAN PATHOLOGY
- An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo
- (2012) T. Zhang et al. JOURNAL OF IMMUNOLOGY
- Phenotypic and Functional Attributes of Lentivirus-modified CD19-specific Human CD8+ Central Memory T Cells Manufactured at Clinical Scale
- (2012) Xiuli Wang et al. JOURNAL OF IMMUNOTHERAPY
- Unknown
- (2012) David Davies et al. MOLECULAR MEDICINE
- Correction: Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth
- (2012) Claire Pearson et al. PLoS One
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
- (2011) Lukas Baitsch et al. JOURNAL OF CLINICAL INVESTIGATION
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells
- (2010) C. H. J. Lamers et al. BLOOD
- Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
- (2010) X. Wang et al. BLOOD
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- B7-H3 and Its Role in Antitumor Immunity
- (2010) Martin Loos et al. Clinical & Developmental Immunology
- Evaluation of B7-H3 Expression as a Biomarker of Biochemical Recurrence After Salvage Radiation Therapy for Recurrent Prostate Cancer
- (2010) Alexander S. Parker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
- (2010) Scott Wilkie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- An Enigmatic Tail of CD28 Signaling
- (2010) J. S. Boomer et al. Cold Spring Harbor Perspectives in Biology
- Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
- (2009) Martin Loos et al. BMC CANCER
- Clinical importance of B7-H3 expression in human pancreatic cancer
- (2009) I Yamato et al. BRITISH JOURNAL OF CANCER
- Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
- (2009) K Birkholz et al. GENE THERAPY
- NKG2D and its ligands
- (2009) Peyman Obeidy et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
- (2009) Chunlei Wu et al. GENOME BIOLOGY
- Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
- (2008) Kui Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
- (2008) Jian Gang Zhang et al. JOURNAL OF NEURO-ONCOLOGY
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma
- (2008) Shahriar S Yaghoubi et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started